AmerisourceBergen Corp (Holding Co) Stock News

Becton Dickinson, McKesson and AmerisourceBergen have been highlighted in this Industry Outlook article.

Here we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors - BDX, MCK and ABC.

Here we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors - BDX, MCK and ABC.

Major Wall Street indices closed in the green on Monday as the focus shifted to the U.S. midterm elections, which will decide which party will control Congress and therefore, spending.  Investors an

AmerisourceBergen's (ABC) fiscal fourth-quarter 2022 results benefit from segmental growth.

AmerisourceBergen's (ABC) fiscal fourth-quarter 2022 results benefit from segmental growth.

AmerisourceBergen Corporation (NYSE:ABC ) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Bennett Murphy - SVP, IR Steven Collis - Chairman, President & CEO James Cle

AmerisourceBergen (ABC) delivered earnings and revenue surprises of 0.78% and 1.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

AmerisourceBergen (ABC) delivered earnings and revenue surprises of 0.78% and 1.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

AmerisourceBergen Corp. ABC, -0.97% said Thursday it had net income of $294.7 million, or $1.40 a share, for its fiscal fourth quarter to Sept. 30, down from $437.7 million, or $2.08 a share, in the y

AmerisourceBergen has won nearly $1.5bn in government contract awards in 2022 up until the end of Q3. 21.3% Y/Y adjusted EPS growth in Q3 2022 driven by strong operating performance & M&A.

Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.

AmerisourceBergen (ABC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

West Pharmaceutical (WST) delivered earnings and revenue surprises of -4.25% and 5.99%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

AmerisourceBergen's (ABC) fiscal fourth-quarter results are likely to reflect solid performance at the U.S. Healthcare Solutions segment.